This analysis examines the Piramal Group’s post-DHFL restructuring across Finance, Pharma, and Realty, situating it alongside the DHFL insolvency to reveal a systemic logic of corporate immunity in India. Through demergers, reverse mergers, and strategic rebrandings, the group consolidated promoter control, quarantined legacy risks, and leveraged regulatory timing while dispersing accountability. Piramal Finance Ltd.’s premium listing, despite DHFL-linked liabilities and opaque asset valuations, exemplifies how market narratives, algorithmic momentum, and legal finality privilege investor perception over depositor justice. Piramal Pharma’s operational stress contrasts with narrative-driven valuation, highlighting structural fragility masked by forward-looking communications. The study demonstrates that restructuring has evolved into a mechanism of reputational cleansing and social erasure, wherein financial architecture advances faster than justice, and ethical accountability is systematically sidelined. Moreover, the chaosophy of the share market—its inherent unpredictability, narrative-driven volatility, and speculative feedback loops—renders conventional risk assessment almost performative, showing how perception, hype, and algorithmic herding often dictate market outcomes more than fundamentals or depositor rights.